Log In
Print this Print this

Bispecific adnectin (EGFR/IGFR tandem adnectin)

  Manage Alerts
Collapse Summary General Information
Company Bristol-Myers Squibb Co.
DescriptionBispecific adnectin inhibitor to epidermal growth factor (EGF) receptor (EGFR) and insulin-like growth factor (IGF) receptor
Molecular Target Epidermal growth factor receptor (EGFR)
Mechanism of ActionEpidermal growth factor (EGF) receptor kinase inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today